96705 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links Tripeptides
Sub-classes:SIV ENVELOPE TRIMER
#2Method for Synthesizing Amide and/or Polypeptide Using Unprotected Amino Acid as Ammonia Component
#3ENZYME-INSTRUCTED SELF-ASSEMBLY OF PEPTIDES CONTAINING N-TERMINAL PHOSPHO-AROMATIC CAPPING MOTIF, AND USES THEREOF
#4PEPTIDE ANTIGENS FOR FORMYLMETHIONINE ANTIBODY PRODUCTION
#5PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#6CYSTEINE REACTIVE PEPTIDES
#7NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF
#8AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#9REGIOSELECTIVE CONJUGATE OF ANTIBODY AND FUNCTIONAL SUBSTANCE OR SALT THEREOF, AND ANTIBODY DERIVATIVE AND COMPOUND USED IN PRODUCTION OF THE SAME OR SALTS THEREOF
#10IMMUNOMODULATORY PEPTIDE
#11PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#12PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#13INHIBITORS OF HUMAN EPIDIDYMUS PROTEIN 4
#14TARGETED NITROXIDE AGENTS
#15Tripeptide propylene oxide derivative and preparation method and application thereof
#16NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF
#17COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION AND WOUND HEALING
#18PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#19Peptide macrocycles against
#20CYCLIC PEPTIDES AS PROTEIN TARGETING AGENTS
#21Method and carrier complexes for delivering molecules to cells
#22Inhibitors of IAP
#23Inhibitors for proliferating cell nuclear antigen and uses
#24Hemiasterlin derivative having cysteine residue
#25PEPTIDE AND METHOD FOR MANUFACTURING SAME
#26PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#27TARGETED NITROXIDE AGENTS
#28PSMA binding ligand-linker conjugates and methods for using
#29Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
#30SIV ENVELOPE TRIMER
#31PSMA binding ligand-linker conjugates and methods for using
#32Molecular imprinted polymers targeting phenylalanine
#33Cyclic peptides as protein targeting agents
#34Peptides Having Anti-Inflammatory Properties
#35PSMA binding ligand-linker conjugates and methods for using
#36Aromatic-cationic peptides and uses of same
#37MALIGNANT TUMOR TARGET PEPTIDE
#38TARGETED NITROXIDE AGENTS
#39Method and carrier complexes for delivering molecules to cells
#40PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#41PSMA binding ligand-linker conjugates and methods for using
#42PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#43ANTIMICROBIAL PEPTIDOMIMETICS
#44PSMA binding ligand-linker conjugates and methods for using
#45PSMA binding ligand-linker conjugates and methods for using
#46Molecular imprinted polymers targeting phenylalanine
#47Peptides and methods and uses thereof for modulating anaphase promoting complex (APC) activity
#48PRODRUG OF AN ICE INHIBITOR
#49Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
#50Inhibitors of hepatitis C virus
#51Immunomodulatory peptide
#52Peptide macrocycles against
#53Group of peptides for treating female sexual dysfunction
#54Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
#55Inhibitors of IAP
#56Malignant tumor target peptide
#57N-lipoic-amino acid or peptide, derivatives and their uses
#58Radiolabeled drug
#59Peptides Having Anti-Inflammatory Properties
#60Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
#61Inhibitors of hepatitis C virus
#62CHIRAL COMPOUNDS OF VARYING CONFORMATIONAL RIGIDITY AND METHODS OF SYNTHESIS
#63AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#64Peptide macrocycles against Acinetobacter baumannii
#65Inhibitors for proliferating cell nuclear antigen and uses
#66COMPOSITION HAVING RICH-TASTE IMPARTING FUNCTION
#67Bifunctional cytotoxic agents
#68PRODRUG OF AN ICE INHIBITOR
#69PSMA binding ligand-linker conjugates and methods for using
#70Targeted nitroxide agents
#71Urea peptoid boric acid compound, pharmaceutical composition thereof, preparation method therefor, and uses thereof
#72PSMA binding ligand-linker conjugates and methods for using
#73PSMA binding ligand-linker conjugates and methods for using
#74PSMA binding ligand-linker conjugates and methods for using
#75PSMA binding ligand-linker conjugates and methods for using
#76PSMA binding ligand-linker conjugates and methods for using
#77PSMA binding ligand-linker conjugates and methods for using
#78PSMA binding ligand-linker conjugates and methods for using
#79Methods for assaying palmitoyl protein thioesterase 1 and tripeptidyl peptidase activity in dried blood spots for detection of neuronal ceroid lipofuscinoses in newborns
#80Method for producing alpha-form crystal of reduced glutathione, and method for storing said crystal
#81Prodrugs of peptide epoxy ketone protease inhibitors
#82NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#83ANTI-MICROBIAL PEPTIDES AND USES OF SAME
#84Derivatives of 1-amino-2-cyclobutylethylboronic acid
#85METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
#86LINEAR PEPTIDE ANTIBIOTICS
#87Microwave-assisted peptide synthesis
#88Compounds for enzyme inhibition
#89PSMA binding ligand-linker conjugates and methods for using
#90Hydroxystatin derivatives for the treatment of arthrosis
#91Method and carrier complexes for delivering molecules to cells
#92Prodrug of an ICE inhibitor
#93Peptides having anti-inflammatory properties
#94Peptide domains that bind small molecules
#95Substrate-mimetic AKT inhibitor
#96Inhibitors of hepatitis C virus
#97Nitrogen-containing compound or salt thereof, or metal complex thereof
#98Peptides and their use in the treatment of skin
#99Targeted nitroxide agents
#100Inhibitors of IAP
#101Peptides having anti-inflammatory properties
#102COMPUNDS FOR ENZYME INHIBITION
#103Microwave-assisted peptide synthesis
#104PSMA binding ligand-linker conjugates and methods for using
#105CRP40 FRAGMENTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#106Process for preparing eptifibatide
#107Method for producing pyrazoles, novel pyrazoles and applications thereof
#108Gadd45beta targeting agents
#109Compounds for enzyme inhibition
#110NOVEL ANTIMICROBIAL AGENTS
#111Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#112Selective targeting agents for mitochondria
#113Functionalized 9-bromo-camptothecin derivatives
#114Prodrug of an ice inhibitor
#115Hydroxystatin derivatives for the treatment of arthrosis
#116Bifunctional cytotoxic agents
#117RFamide-related peptides and methods thereof
#118COSMETIC OR PHARMACEUTICAL COMPOSITIONS INCLUDING TRIPEPTIDES CAPABLE OF STIMULATING CYCLIC ADENOSINE MONOPHOSPHATE SYNTHESIS AND THEIR USE IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR
#119INHIBITORS OF HEPATITIS C VIRUS
#120Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#121Peptoids useful for the mineralization of apatite
#122Linear peptide antibiotics
#123Macrocyclic modulators of the ghrelin receptor
#124Cyclic peptides as protein targeting agents
#125INHIBITORS OF HCV NS5A
#126PROCESS FOR THE SYNTHESIS OF TELAPREVIR, OR PHARMACEUTICALLY ACCEPTABLE SALTS OR SOLVATES AS WELL AS INTERMEDIATE PRODUCTS THEREOF
#127Microwave-assisted peptide synthesis
#128Substrate-mimetic Akt inhibitor
#129Inhibitors of hepatitis C virus replication
#130Functionalizing reagents and their uses
#131Immunoconjugates, compositions for making them, and methods of making and use
#132Organic compounds and their uses
#133Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase
#134Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
#135Compounds, compositions and methods for the treatment of diseases through inhibiting TGF-β activity
#136Modulators of protease activated receptors
#137DPP-4 inhibitor
#138Peptidomimetics and their application
#139SELECTIVE GPCR LIGANDS
#140HCV NS3 protease inhibitors
#141NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#142AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#143Chiral oligomeric pentenoate amides as bio-oligomer mimetics
#144PEPTOID NEUTRALIZING AGENTS
#145PEPTOID NEUTRALIZING AGENTS
#146Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#147Treatments for
#148Inhibitors of IAP
#149Pyrrolobenzodiazepines
#150Versatile native chemical ligation technologies
#151RNA targeting compounds and methods for making and using same
#152Derivatives of 1-amino-2-cyclobutylethylboronic acid
#153Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
#154Process for preparing eptifibatide
#155METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
#156Macrocyclic broad spectrum antibiotics
#157Smac mimetic dimers and trimers useful as anti-cancer agents
#158Induction of the mitochondrial permeability transition
#159Active agent prodrugs with heterocyclic linkers
#160Selective targeting agents for mitochondria
#161Prodrugs of Peptide Epoxy Ketone Protease Inhibitors
#162Prodrugs of peptide epoxy ketone protease inhibitors
#163Prodrugs of peptide epoxy ketone protease inhibitors
#164Amphiphilic linear peptidepeptoid and hydrogel comprising the same
#165Anti-microbial peptides and uses of same
#166COMPOUNDS FOR ENZYME INHIBITION
#167PSMA binding ligand-linker conjugates and methods for using
#168HCV NS3 protease inhibitors
#169Methods for preparing internally constrained peptides and peptidomimetics
#170AMYLOID-BETA PEPTIDE CRYSTAL STRUCTURE
#171Inhibitors of hepatitis C virus
#172RGD mimetic γ-AApeptides and methods of use
#173Prodrug of an ice inhibitor
#174Process for the manufacture of Degarelix and its intermediates
#175Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor Ligands
#176Growth hormone secretatogue receptor antagonists and uses thereof
#177AMINO ACID DERIVATIVES; COMPOSITIONS CONTAINING THEM; USE AS AGENTS FOR TREATING HUMAN PERSPIRATION
#178Medical device with predefined activated cellular integration
#179Methods and compositions for treating brain diseases
#180Peptide domains that bind small molecules of industrial significance
#181Method and carrier complexes for delivering molecules to cells
#182Compounds for enzyme inhibition
#183Compounds for enzyme inhibition
#184Compounds for enzyme inhibition
#185Peptidomimetic sulfamide compounds and antiviral uses thereof
#186Peptidomimetic sulfamide compounds and antiviral uses thereof
#187Methods for Preparing Internally Constrained Peptides and Peptidomimetics
#188Immunoconjugates, compositions for making them, and methods of making and use
#189Gadd45beta targeting agents
#190Tripeptide boronic acid or boronic ester, preparative method and use thereof
#191Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#192Proteasome-activating lightening peptidic hydrolyzates and compositions containing them
#193Compounds for enzyme inhibition
#194Inhibitors of hepatitis C virus replication
#195Microwave-assisted peptide synthesis
#196Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#197Rapid FRET-based diagnosis of bacterial pathogens
#198PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
#199Prodrug of an ICE inhibitor
#200Amyloid-beta peptide crystal structure
#201Inhibitors of mammalian tight junction opening
#202HCV NS3 protease inhibitors
#203Selective Targeting Agents for Mitochondria
#204PSMA binding ligand-linker conjugates and methods for using
#205BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM
#206Epithelial cell growth promoter
#207Activating peptide of the synthesis of aquaporins and cosmetic and/or pharmaceutical composition containing it
#208Derivatised proline containing peptide compounds as protease inhibitors
#209Methods for preparing internally constrained peptides and peptidomimetics
#210Method and carrier complexes for delivering molecules to cells
#211DIMERIC IAP INHIBITORS
#212Compounds for enzyme inhibition
#213Compounds for enzyme inhibition
#214Derivatives of 1-amino-2-cyclobutylethylboronic acid
#215Microwave-assisted peptide synthesis
#216HEPARAN SULFATE INHIBITORS
#217Targeted nitroxide agents
#218Substrate-mimetic Akt inhibitor
#219Phosphonyl ester conjugates as prodrugs
#220Microwave-assisted peptide synthesis
#221Compounds for enzyme inhibition
#222Methods and compositions for treating brain diseases
#223Smac mimetic dimers and trimers useful as anti-cancer agents
#224IMMUNOMODULATING OLIGOPEPTIDES
#225Microwave-assisted peptide synthesis
#226Prodrug of an ICE inhibitor
#227Compounds for enzyme inhibition
#228Epithelial cell growth promoter
#229Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
#230Methods for preparing internally constrained peptides and peptidomimetics
#231Hypoglycemic agent
#232Hypoglycemic agent
#233Hypoglycemic agent
#234Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#235Compounds for enzyme inhibition
#236Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same
#237Bile-acid conjugates providing for sustained systemic concentration of drugs
#238Induction of the mitochondrial permeability transition
#239Cidofovir peptide conjugates as prodrugs
#240Substrates for TAFI (A)
#241Microwave-assisted peptide synthesis
#242Microwave-assisted peptide synthesis
#243Microwave-assisted peptide synthesis
#244Methods for preparing internally constrained peptides and peptidomimetics
#245Bile-acid conjugates for providing sustained systemic concentrations of drugs
#246Method and carrier complexes for delivering molecules to cells
#247Bile-acid conjugates providing for sustained systemic concentration of drugs
#248Hypoglycemic agent
#249Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
#250Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
#251Homing peptides
#252Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#253Compound, composition, and method for detecting caspase activity and/or apoptosis